SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The company will display the system throughout the event, with highlights including multiple breakout sessions and a live broadcast of a remote partial nephrectomy. The surgery, performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, will be conducted on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in sessions covering telesurgery, robotic surgery adoption, regulatory frameworks and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries and 225 pediatric surgeries. Approximately 2,100 physicians have been trained on the platform.
The SSi Mantra system is designed to make robotic surgery more affordable and accessible globally. SS Innovations develops innovative surgical robotic technologies, including the SSi Mantra and the SSi Mudra surgical instruments, which support a variety of procedures including cardiac surgery. The company, an American firm headquartered in India, aims to expand the global presence of its cost-effective solutions.
The implications of this announcement are significant. The live telesurgery demonstration underscores the potential for remote surgical procedures to bridge geographic gaps in healthcare access. With over 178 telesurgeries already performed, SS Innovations is demonstrating a viable path for expert surgeons to operate on patients in distant locations. This could be particularly transformative for regions lacking specialized surgical expertise, potentially reducing the need for patient travel and enabling timely interventions.
Furthermore, the company's focus on regulatory frameworks and global access at the conference highlights the ongoing efforts to standardize telesurgery protocols and ensure patient safety. As robotic surgery adoption grows, the need for clear regulations becomes critical. SS Innovations' involvement in these discussions positions it as a key player in shaping the future of surgical robotics.
The data on procedures and training also indicate increasing acceptance and integration of the SSi Mantra system into clinical practice. The wide range of procedure types, including cardiac and pediatric surgeries, demonstrates the system's versatility. As more physicians are trained, the potential for widespread adoption increases, which could drive down costs and improve patient outcomes globally.
For more information, view the full press release at https://ibn.fm/YYYKE. Additional details about the company can be found on the InvestorBrandNetwork website, including terms of use and disclaimers at http://IBN.fm/Disclaimer.
